Prediction of clinically significant prostate cancer using radiomics models in real-world clinical practice: a retrospective multicenter study

被引：0
|
作者：
Jie Bao
Xiaomeng Qiao
Yang Song
Yueting Su
Libiao Ji
Junkang Shen
Guang Yang
Hailin Shen
Ximing Wang
Chunhong Hu
机构：
[1] The First Affiliated Hospital of Soochow University,Department of Radiology
[2] Siemens Healthineers,Scientific Marketing
[3] The People’s Hospital of Taizhou,Department of Radiology
[4] Changshu NO.1 People’s Hospital,Department of Radiology
[5] The Second Affiliated Hospital of Soochow University,Department of Radiology
[6] East China Normal University,Shanghai Key Laboratory of Magnetic Resonance
[7] Suzhou Kowloon Hospital,Department of Radiology
[8] Shanghai Jiaotong University School of Medicine,undefined
来源：
Insights into Imaging | / 15卷
关键词：
Neoplasms, Prostatic, Magnetic resonance imaging, Random forest, Retrospective study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Initial experience with SelectMDx® in the diagnosis of prostate cancer in a real-world evidence clinical practice setting
    Quintana, L. M.
    Fernandez Pascual, E.
    Linares Espinos, E.
    Martinez-Ballesteros, C.
    Martin-Vivas, C.
    Rengifo Abbad, D.
    d'Anna Caruso, N.
    Allona, A.
    Martinez-Salamanca, J., I
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (06): : 400 - 407
  • [32] Palbociclib Is Safe for Breast Cancer Patients With Mild Hepatic Impairment: A Multicenter Retrospective Study Using Real-World Data
    Bos, Alieke K.
    Willemsen, Annelieke E. C. A. B.
    Visser, Loes E.
    Stoker, Lennart J.
    Kingma, Jurjen S.
    Rommers, Mirjam K.
    Kuck, Emile M.
    van Der Linden, Paul D.
    van Nuland, Merel
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [33] Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
    Amelia J. Averitt
    Chunhua Weng
    Patrick Ryan
    Adler Perotte
    npj Digital Medicine, 3
  • [34] Diagnostic nomogram based on intralesional and perilesional radiomics features and clinical factors of clinically significant prostate cancer
    Zhang, Han
    Li, Xianglin
    Zhang, Yongxia
    Huang, Cheng
    Wang, Yongqiang
    Yang, Ping
    Duan, Shaofeng
    Mao, Ning
    Xie, Haizhu
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 53 (05) : 1550 - 1558
  • [35] Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
    Averitt, Amelia J.
    Weng, Chunhua
    Ryan, Patrick
    Perotte, Adler
    NPJ DIGITAL MEDICINE, 2020, 3 (01)
  • [36] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Hiroaki Kanzaki
    Sadahisa Ogasawara
    Tomomi Okubo
    Norio Itokawa
    Ryohei Yoshino
    Kentaro Fujimoto
    Tadayoshi Kogure
    Sae Yumita
    Takamasa Ishino
    Keita Ogawa
    Terunao Iwanaga
    Miyuki Nakagawa
    Kisako Fujiwara
    Ryuta Kojima
    Keisuke Koroki
    Masanori Inoue
    Kazufumi Kobayashi
    Naoya Kanogawa
    Soichiro Kiyono
    Masato Nakamura
    Takayuki Kondo
    Ryo Nakagawa
    Shingo Nakamoto
    Ryosuke Muroyama
    Ei Itobayashi
    Masanori Atsukawa
    Jun Kato
    Naoya Kato
    Drugs - Real World Outcomes, 2023, 10 : 513 - 520
  • [37] TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
    Pisano, Chiara
    Turco, Fabio
    Arnaudo, Elena
    Fea, Elena
    Vanella, Paola
    Ruatta, Fiorella
    Filippi, Roberto
    Brusa, Federica
    Prati, Veronica
    Vana, Federica
    Mennitto, Alessia
    Cattrini, Carlo
    Vignani, Francesca
    Dionisio, Rossana
    Icardi, Massimiliano
    Guglielmini, Pamela
    Buosi, Roberta
    Stevani, Ilaria
    Vormola, Roberto
    Numico, Gianmauro
    Depetris, Ilaria
    Comandone, Alessandro
    Gennari, Alessandra
    Rossi, Maura
    Airoldi, Mario
    Vellani, Giorgio
    Ortega, Cinzia
    Tucci, Marcello
    Di Maio, Massimo
    Buttigliero, Consuelo
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 56 - 67.e16
  • [38] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Kanzaki, Hiroaki
    Ogasawara, Sadahisa
    Okubo, Tomomi
    Itokawa, Norio
    Yoshino, Ryohei
    Fujimoto, Kentaro
    Kogure, Tadayoshi
    Yumita, Sae
    Ishino, Takamasa
    Ogawa, Keita
    Iwanaga, Terunao
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Kojima, Ryuta
    Koroki, Keisuke
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Itobayashi, Ei
    Atsukawa, Masanori
    Kato, Jun
    Kato, Naoya
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (04) : 513 - 520
  • [39] A Study on Treatment and Characteristics of Prostate Cancer Patients Using Real-World Data
    Miranda, Jamilette
    Lilja, Birgitta
    Wettermark, Bjoern
    Ljunggren, Gunnar
    Henriksson, Roger
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 533 - 533
  • [40] Efficacy and Safety of Naldemedine for Patients with Cancer with Opioid-Induced Constipation in Clinical Practice: A Real-World Retrospective Study
    Nishiba, Hiromi
    Imai, Hisao
    Fujita, Yukiyoshi
    Hiruta, Eriko
    Masuno, Takashi
    Yamazaki, Shigeki
    Tanaka, Hajime
    Kamiya, Teruhiko
    Ito, Masako
    Takei, Satoshi
    Matsuura, Masato
    Mogi, Junnosuke
    Minato, Koichi
    Obayashi, Kyoko
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
12345